Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Jeff Somers is a freelancer who has been writing about writing, books, personal finance, and home maintenance since 2012. When not writing, Jeff spends his free time fixing up his old house. He has ...

Whether it's snow or ice, winter storms always carry the risk of power outages — and without access to heating, lights, and chargers, things can turn from inconvenient to downright dangerous in the ...

This story contains descriptions of explicit sexual content and sexual violence. Elon Musk’s Grok chatbot has drawn outrage and calls for investigation after being used to flood X with “undressed” ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Have you ever tried mixing oil and water?

Eeny, meeny, miny, mo, catch a tiger by the toe – so the rhyme goes. But even children know that counting-out rhymes like this are no help at making a truly random choice. Perhaps you remember when ...

BUFFALO, N.Y. — The owner of 110 and 118 South Park Ave, Darryl Carr, had his lawsuit against the city of Buffalo reinstated after the Appellate Division, Fourth Department reversed a lower courts ...